The difference in serum proteomes in schizophrenia and bipolar disorder

• Published in: BMC genomics 2019-07, Vol.20 (Suppl 7), p.535-14, Article 535
• Main Authors: Smirnova, Liudmila, Seregin, Alexander, Boksha, Irina, Dmitrieva, Elena, Simutkin, German, Kornetova, Elena, Savushkina, Olga, Letova, Anastasia, Bokhan, Nikolay, Ivanova, Svetlana, Zgoda, Victor
• Format: Article
• Language: English
• Subjects: Adult; Antigens, CD - metabolism; Biological products; Biomarker; Bipolar disorder; Bipolar Disorder - metabolism; Blood proteins; Blood serum; Cadherins - metabolism; Cell membranes; Cellular proteins; Composition; Diagnosis; Enzyme-linked immunosorbent assay; Female; Health aspects; Humans; Immune response; Male; Mass spectrometry; Middle Aged; Neurons; Nuclear Proteins - metabolism; Nucleic acids; Proteins; Proteome; Proteome - metabolism; Proteomics; Psychotic disorders; Schizophrenia; Schizophrenia - metabolism; Serum; Spectroscopy; Young Adult
• ISSN: 1471-2164; 1471-2164
• DOI: 10.1186/s12864-019-5848-1

Purpose of study is revealing significant differences in serum proteomes in schizophrenia and bipolar disorder (BD). Quantitative mass-spectrometry based proteomic analysis was used to quantify proteins in the blood serum samples after the depletion of six major blood proteins. Comparison of proteome profiles of different groups revealed 27 proteins being specific for schizophrenia, and 18 - for BD. Protein set in schizophrenia was mostly associated with immune response, cell communication, cell growth and maintenance, protein metabolism and regulation of nucleic acid metabolism. Protein set in BD was mostly associated with immune response, regulating transport processes across cell membrane and cell communication, development of neurons and oligodendrocytes and cell growth. Concentrations of ankyrin repeat domain-containing protein 12 (ANKRD12) and cadherin 5 in serum samples were determined by ELISA. Significant difference between three groups was revealed in ANKRD12 concentration (p = 0.02), with maximum elevation of ANKRD12 concentration (median level) in schizophrenia followed by BD. Cadherin 5 concentration differed significantly (p = 0.035) between schizophrenic patients with prevailing positive symptoms (4.78 [2.71, 7.12] ng/ml) and those with prevailing negative symptoms (1.86 [0.001, 4.11] ng/ml). Our results are presumably useful for discovering the new pathways involved in endogenous psychotic disorders.